Search Orphan Drug Designations and Approvals
-
Generic Name: | Hydrocortisone | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Trade Name: | ALKINDI® SPRINKLE | |||||||||||||
Date Designated: | 05/13/2015 | |||||||||||||
Orphan Designation: | Treatment of pediatric adrenal insufficiency (0 through 16 years of age). | |||||||||||||
Orphan Designation Status: | Designated/Approved | |||||||||||||
Sponsor: |
Eton Pharmaceuticals, Inc. 21925 West Field Parkway, Suite 235 Deer Park, Illinois 60010 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
|||||||||||||
Marketing approved: |
||||||||||||||
1 | Generic Name: | Hydrocortisone |
---|---|---|
Trade Name: | ALKINDI® SPRINKLE | |
Marketing Approval Date: | 09/29/2020 | |
Approved Labeled Indication: | ALKINDI® SPRINKLE is indicated as replacement therapy in pediatric patients with adrenocortical insufficiency | |
Exclusivity End Date: | TBD | |
2 | Generic Name: | hydrocortisone |
---|---|---|
Trade Name: | Khindivi | |
Marketing Approval Date: | 05/28/2025 | |
Approved Labeled Indication: | replacement therapy in pediatric patients 5 years of age and older with adrenocortical insufficiency | |
Exclusivity End Date: | TBD | |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-